Hematologic Malignancy
Adult Burkitt Lymphoma
CI-CAN-00007166Explore in graph →
Hematologic3 active trials
- NCIt
- C9062
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00007166Explore in graph →
Clinical trials
107 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (25)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07662928 | Epcoritamab in Combination With Dose Adjusted EPOCH-R for High-risk Burkitt Lymphoma (BL), The BEDROCK Study | not yet recruiting | Phase 2 | 43 | AIDS Malignancy ConsortiumNETWORK | 1 | Aug 14, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Aug 14, 2026source: clinicaltrials